In the Middle East and Africa pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total value of $1bn, according to GlobalData’s Deals Database. The $1bn majority acquisition of Aster DM Healthcare FZC by Alpha GCC was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for 2023 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Buy the report here.
In value terms, M&A activity in Middle East and Africa increased by 677% in Q4 2023 compared with the previous quarter’s total of $128.7m. Related deal volume decreased by 13% in Q4 2023 versus the previous quarter and was 17% higher than in Q4 2022.
The top-ranked financial advisors supporting these M&A deals in Middle East and Africa in Q4 2023 were Ernst & Young Global; Gulf International Bank; HSBC with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these M&A deals in Middle East and Africa Q4 2023 were Baker & McKenzie; Baratz, Horn & Co.; Clifford Chance with 1, 1, 1 deals respectively.
See Also:
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in 2023 – Thematic Intelligence, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.